Iambic Therapeutics, Inc. (IAM) SEC filings
IAMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$13.10−1.74 (-11.73%)
Close on Nov 13, 2026Market cap –P/E –Yield –
SEC filings
1 of Iambic Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 16, 2026 | Oct 16, 2026 | SEC EDGAR |
See a number that looks wrong?